Based on these results, 18F-florbetaben has also been evaluated for cardiac amyloidosis [5–7] and found it was able to accurately identify and differentiate between cardiac amyloidosis (both Al and TTR) and hypertensive heart disease [5]. Here, TTR is linked to cardiac amyloidosis.